Are there enhanced MBP autoantibodies in autism?

Journal of Autism and Developmental Disorders

Volumn 38, Issue 2, 2008, Pages 324-332

  Libbey, Jane E ^a   Coon, Hilary H ^a   Kirkman, Nikki J ^a   Sweeten, Thayne L ^a   Miller, Judith N ^a   Stevenson, Edward K ^a   Lainhart, Janet E ^a   McMahon, William M ^a   Fujinami, Robert S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Autism; Autoantibody; Immunoglobulin; Myelin basic protein; Tourette syndrome

Indexed keywords

MYELIN BASIC PROTEIN;

ANTIBODY DETECTION; ARTICLE; AUTISM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GILLES DE LA TOURETTE SYNDROME; HUMAN; PRIORITY JOURNAL; WESTERN BLOTTING;

AUTISTIC DISORDER; AUTOANTIBODIES; AXONS; BLOTTING, WESTERN; BRAIN; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTONES; HUMANS; MALE; MYELIN BASIC PROTEINS; MYELIN SHEATH; REFERENCE VALUES; TOURETTE SYNDROME;

EID: 38549085855     PISSN: 01623257     EISSN: 15733432     Source Type: Journal    
DOI: 10.1007/s10803-007-0400-6     Document Type: Article

References (56)

1. Alexander, A. L., Lee, J. E., Lazar, M., Boudos, R., Dubray, M. B., Oakes, T. R., Miller, J. N., Lu, J., Jeong, E. K., McMahon, W. M., Bigler, E. D., & Lainhart, J. E. (2007). Diffusion tensor imaging of the corpus callosum in Autism. Neuroimage, 34, 61-73.
2. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders (4th ed.), Text Revision. Washington, DC.
3. Bailey, A., Le Couteur, A., Gottesman, I., Bolton, P., Simonoff, E., Yuzda, E., & Rutter, M. (1995). Autism as a strongly genetic disorder: evidence from a British twin study. Psychology of Medicine, 25, 63-77.
4. Bailey, A., Luthert, P., Dean, A., Harding, B., Janota, I., Montgomery, M., Rutter, M., & Lantos, P. (1998). A clinicopathological study of autism. Brain, 121, 889-905.
5. Barnea-Goraly, N., Kwon, H., Menon, V., Eliez, S., Lotspeich, L., & Reiss, A. L. (2004). White matter structure in autism: Preliminary evidence from diffusion tensor imaging. Biological Psychiatry, 55, 323-326.
6. Boger-Megiddo, I., Shaw, D. W., Friedman, S. D., Sparks, B. F., Artru, A. A., Giedd, J. N., Dawson, G., & Dager, S. R. (2006). Corpus callosum morphometrics in young children with autism spectrum disorder. Journal of Autism and Developmental Disorders, 36, 733-739.
7. Borenstein, M., Rothstein, H., & Cohen, J. (2000). Power and Precision, version 2.0. www.PowerAndPrecision.com.
8. Chakrabarti, S., & Fombonne, E. (2001). Pervasive developmental disorders in preschool children. Journal of the American Medical Association, 285, 3093-3099.
9. Chung, M. K., Dalton, K. M., Alexander, A. L., & Davidson, R. J. (2004). Less white matter concentration in autism: 2D voxel-based morphometry. Neuroimage, 23, 242-251.
10. Coleman, M., & Gillberg, C. (1985). The biology of the autistic syndromes. New York: Praeger Publishers.
11. Connolly, A. M., Chez, M., Streif, E. M., Keeling, R. M., Golumbek, P. T., Kwon, J. M., Riviello, J. J., Robinson, R. G., Neuman, R. J., & Deuel, R. M. K. (2006). Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biological Psychiatry, 59, 354-363.
12. Connolly, A. M., Chez, M. G., Pestronk, A., Arnold, S. T., Mehta, S., & Deuel, R. K. (1999). Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. Journal of Pediatrics, 134, 607-613.
13. Courchesne, E., Karns, C. M., Davis, H. R., Ziccardi, R., Carper, R. A., Tigue, Z. D., Chisum, H. J., Moses, P., Pierce, K., Lord, C., Lincoln, A. J., Pizzo, S., Schreibman, L., Haas, R. H., Akshoomoff, N. A., & Courchesne, R. Y. (2001). Unusual brain growth patterns in early life in patients with autistic disorder: An MRI study. Neurology, 57, 245-254.
14. Deibler, G. E., Martenson, R. E., & Kies, M. W. (1972). Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Preparative Biochemistry, 2, 139-165.
15. Detskey, P. Z., Bigbee, J. W., & DeVries, G. H. (1988). Isolation and characterization of axolemma-enriched fractions from discrete areas of bovine CNS. Neurochemical Research, 13, 449-454.
16. Egaas, B., Courchesne, E., & Saitoh, O. (1995). Reduced size of corpus callosum in autism. Archives of Neurology, 52, 794-801.
17. Filipek, P. A. (1996). Brief report: neuroimaging in autism: The state of the science 1995. Journal of Autism and Developmental Disorders, 26, 211-215.
18. Fombonne, E. (2003). The prevalence of autism. Journal of the American Medical Association, 289, 87-89.
19. Fujinami, R. S., Zurbriggen, A., & Powell, H. C. (1988). Monoclonal antibody defines determinant between Theiler's virus and lipid-like structures. Journal of Neuroimmunology, 20, 25-32.
20. Gillberg, C., & Wing, L. (1999). Autism: Not an extremely rare disorder. Acta Psychiatra Scandinavica, 99, 399-406.
21. Goldberg, W. A., Osann, K., Filipek, P. A., Laulhere, T., Jarvis, K., Modahl, C., Flodman, P., & Spence, M. A. (2003). Language and other regression: Assessment and timing. Journal of Autism and Developmental Disorders, 33, 607-616.
22. Hardan, A. Y., Minshew, N. J., & Keshavan, M. S. (2000). Corpus callosum size in autism. Neurology, 55, 1033-1036.
23. Herbert, M. R., Ziegler, D. A., Makris, N., Filipek, P. A., Kemper, T. L., Normandin, J. J., Sanders, H. A., Kennedy, D. N., & Caviness, V. S., Jr. (2004). Localization of white matter volume increase in autism and developmental language disorder. Annals of Neurology, 55, 530-540.
24. Husted, C. (2006). Structural insight into the role of myelin basic protein in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America, 103, 4339-4340.
25. Jankovic, J. (2001). Tourette's syndrome. New England Journal of Medicine, 345, 1184-1192.
26. Just, M. A., Cherkassky, V. L., Keller, T. A., & Minshew, N. J. (2004). Cortical activation and synchronization during sentence comprehension in high-functioning autism: Evidence of underconnectivity. Brain, 127, 1811-1821.
27. Kirkman, N. K., Libbey, J. E., Sweeten, T. L., Coon, H. H., Miller, J. N., Stevenson, E. K., Lainhart, J. E., McMahon, W. M., & Fujinami, R. S. (in press). How relevant are GFAP autoantibodies in autism? Journal of Autism and Developmental Disorders.
28. Kiessling, L. S., Marcotte, A. C., & Culpepper, L. (1993). Antineuronal antibodies in movement disorders. Pediatrics, 92, 39-43.
29. Lainhart, J. E., Bigler, E. D., Bocian, M., Coon, H., Dinh, E., Dawson, G., Deutsch, C. K., Dunn, M., Estes, A., Tager-Flusberg, H., Folstein, S., Hepburn, S., Hyman, S., McMahon, W., Minshew, N., Munson, J., Osann, K., Ozonoff, S., Rodier, P., Rogers, S., Sigman, M., Spence, M. A., Stodgell, C. J., & Volkmar, F. (2006). Head circumference and height in autism: A study by the collaborative program of excellence in autism. American Journal of Medical Genetics Part A, 140, 2257-2274.
30. Luyster, R., Richler, J., Risi, S., Hsu, W.-L., Dawson, G., Bernier, R., Dunn, M., Hepburn, S., Hyman, S. L., McMahon, W. M., Goudie-Nice, J., Minshew, N., Rogers, S., Sigman, M., Spence, M. A., Goldberg, W. A., Tager-Flusberg, H., Volkmar, F. R., & Lord, C. (2005). Early regression in social communication in autism spectrum disorders: A CPEA Study. Developmental Neuropsychology, 27, 311-336.
31. Manes, F., Piven, J., Vrancic, D., Nanclares, V., Plebst, C., & Starkstein, S. E. (1999). An MRI study of the corpus callosum and cerebellum in mentally retarded autistic individuals. Journal of Neuropsychiatry and Clinical Neurosciences, 11, 470-474.
32. Minshew, N. J., Goldstein, G., & Siegel, D. J. (1997). Neuropsychologic functioning in autism: profile of a complex information processing disorder. Journal of the International Neuropsychological Society, 3, 303-316.
33. Musse, A. A., Boggs, J. M., & Harauz, G. (2006). Deimination of membrane-bound myelin basic protein in multiple sclerosis exposes an immunodominant epitope. Proceedings of the National Academy of Sciences of the United States of America, 103, 4422-4427.
34. Nelson, K. B. (1991). Prenatal and perinatal factors in the etiology of autism. Pediatrics, 87, 761-766.
35. Piven, J., Bailey, J., Ranson, B. J., & Arndt, S. (1997). An MRI study of the corpus callosum in autism. American Journal of Psychiatry, 154, 1051-1056.
36. Plioplys, A. V., Greaves, A., Kazemi, K., & Silverman, E. (1994). Immunoglobin reactivity in autism and Rett's syndrome. Developmental Brain Dysfunction, 7, 12-16.
37. Sambrook, J., Fritsch, E. F., & Maniatis, T. (1989). Molecular cloning: A laboratory manual. New York: Cold Spring Harbor Laboratory.
38. Schotte, A., Janssen, P. F., Megens, A. A., & Leysen, J. E. (1993). Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Research, 631, 191-202.
39. Singer, H. S., Giuliano, J. D., Hansen, B. H., Hallett, J. J., Laurino, J. P., Benson, M., & Kiessling, L. S. (1998). Antibodies against human putamen in children with Tourette's syndrome. Neurology, 50, 1618-1624.
40. Singer, H. S., Morris, C. M., Williams, P. N., Yoon, D. Y., Hong, J. J., & Zimmerman, A. W. (2006). Antibrain antibodies in children with autism and their unaffected siblings. Journal of Neuroimmunology, 178, 149-155.
41. Singh, V. K., Lin, S. X., Newell, E., & Nelson, C. (2002). Abnormal measles-mumps-rubella antibodies and CNS autoimmunity in children with autism. Journal of Biomedical Science, 9, 359-364.
42. Singh, V. K., Lin, S. X., & Yang, V. C. (1998). Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clinical Immunology and Immunopathology, 89, 105-108.
43. Singh, V. K., & Rivas, W. H. (2004). Prevalence of serum antibodies to caudate nucleus in autistic children. Neuroscience Letters, 355, 53-56.
44. Singh, V. K., Warren, R., Averett, R., & Ghaziuddin, M. (1997). Circulating autoantibodies to neuronal and glial filament proteins in autism. Pediatric Neurology, 17, 88-90.
45. Singh, V. K., Warren, R. P., Odell, J. D., Warren, W. L., & Cole, P. (1993). Antibodies to myelin basic protein in children with autistic behavior. Brain Behavior and Immunity, 7, 97-103.
46. Swedo, S. E., Leonard, H. L., Garvey, M., Mittleman, B., Allen, A. J., Perlmutter, S., Lougee, L., Dow, S., Zamkoff, J., & Dubbert, B. K. (1998). Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. American Journal of Psychiatry, 155, 264-271.
47. Tolley, N. D., Tsunoda, I., & Fujinami, R. S. (1999). DNA vaccination against Theiler's murine encephalomyelitis virus leads to alterations in demyelinating disease. Journal of Virology, 73, 993-1000.
48. Vargas, D. L., Nascimbene, C., Krishnan, C., Zimmerman, A. W., & Pardo, C. A. (2005). Neuroglial activation and neuroinflammation in the brain of patients with autism. Annals of Neurology, 57, 67-81.
49. Vidal, C. N., Nicolson, R., DeVito, T. J., Hayashi, K. M., Geaga, J. A., Drost, D. J., Williamson, P. C., Rajakumar, N., Sui, Y., Dutton, R. A., Toga, A. W., & Thompson, P. M. (2006). Mapping corpus callosum deficits in autism: an index of aberrant cortical connectivity. Biological Psychiatry, 60, 218-225.
50. Vojdani, A., Campbell, A. W., Anyanwu, E., Kashanian, A., Bock, K., & Vojdani, E. (2002). Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A. Journal of Neuroimmunology, 129, 168-177.
51. Waiter, G. D., Williams, J. H., Murray, A. D., Gilchrist, A., Perrett, D. I., & Whiten, A. (2005). Structural white matter deficits in high-functioning individuals with autistic spectrum disorder: A voxel-based investigation. Neuroimage, 24, 455-461.
52. Yamada, M., Zurbriggen, A., Oldstone, M. B. A., & Fujinami, R. S. (1991). Common immunologic determinant between human immunodeficiency virus type 1 gp41 and astrocytes. Journal of Virology, 65, 1370-1376.
53. Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003). Prevalence of autism in a US metropolitan area. Journal of the American Medical Association, 289, 49-55.
54. Yeh, C.-B., Wu, C.-H., Tsung, H.-C., Chen, C.-W., Shyu, J.-F., & Leckman, J. F. (2006). Antineural antibody in patients with Tourette's syndrome and their family members. Journal of Biomedical Science, 13, 101-112.
55. Zimmerman, A. W., Connors, S. L., Matteson, K. J., Lee, L. C., Singer, H. S., Castaneda, J. A., & Pearce, D. A. (2007). Maternal antibrain antibodies in autism. Brain Behavior and Immunity, 21, 351-357.
56. Zimmerman, A. W., Jyonouchi, H., Comi, A. M., Connors, S. L., Milstien, S., Varsou, A., & Heyes, M. P. (2005). Cerebrospinal fluid and serum markers of inflammation in autism. Pediatric Neurology, 33, 195-201.